Abstract: An improved mixed metal oxide material suitable for use in electrochemical cells is provided. The mixed metal oxide material generally exhibits high surface area and pore volume than conventionally manufactured materials thereby imparting improved electrochemical performance. Batteries manufactured using the mixed metal oxide material are particularly suited for use in implantable medical devices.

Abstract: Methods of reducing smoke levels in smoke-affected areas, reducing the level of toxic compounds produced by fires, fire suppression, and increasing flame retardancy. In particular, methods according to the present invention comprise dispersing nanocrystalline particles in the areas affected by smoke for sorption of smoke particulates and toxic compounds produced from a fire. The nanocrystalline particles are also effective for use in methods of fire suppression and flame retardancy.

Abstract: Compositions and methods for destroying chemical and biological agents such as toxins and bacteria are provided wherein the substance to be destroyed is contacted with finely divided metal oxide nanoparticles. The metal oxide nanoparticles are coated with a material selected from the group consisting of surfactants, waxes, oils, silyls, synthetic and natural polymers, resins, and mixtures thereof. The coatings are selected for their tendency to exclude water while not excluding the target compound or adsorbates. The desired metal oxide nanoparticles can be pressed into pellets for use when a powder is not feasible. Preferred metal oxides for the methods include MgO, SrO, BaO, CaO, TiO2, ZrO2, FeO, V2O3, V2O5, Mn2O3, Fe2O3, NiO, CuO, Al2O3, SiO2, ZnO, Ag2O, the corresponding hydroxides of the foregoing, and mixtures thereof.

Abstract: Disclosed is a method and apparatus for the quantification of solute removal during hemodialysis. The method relies upon discontinuing the flow of fresh dialysate to the dialyzer and recirculating the dialysate in a closed loop through the dialyzer. Recirculation is continued until a steady state concentration of solute (e.g. urea) in the dialysate is achieved. Analysis of the dialysate by suitable means at this time yields a value equal to the solute concentration in the blood without the need for blood sampling. Normal dialysis is resumed by discontinuing the recirculation and providing fresh dialysate to the dialyzer. Determination of solute concentrations at least at the beginning and end of the dialysis period allows the determination of solute loss and the quantification of dialysis therapy and its on-line prescription.